AI assistant
Bridgepoint Group PLC M&A Activity 2023
5352_tar_2023-10-20_eb48985e-3bbb-4bf5-89f8-6c886b2ca56d.html
M&A Activity
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information 
RNS Number : 8608Q
Bridgepoint Group plc
20 October 2023
THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT CONSTITUTE AN OFFER FOR SALE OF ANY SECURITIES OR AN OFFER OR INVITATION TO PURCHASE ANY SECURITIES IN ANY JURISDICTION OR A SOLICITATION OF ANY VOTE OR APPROVAL.
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (DIRECTLY OR INDIRECTLY) IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.
Bridgepoint Group plc
("Bridgepoint" or the "Company")
Update on Transaction
Further to Bridgepoint's announcement on 6 September 2023 regarding the agreement to add Energy Capital Partners Holdings, LP and affiliated entities to its platform (the "Transaction"), the Company is pleased to announce that it has been informed that required investor consents to the Transaction have been received for ECP Fund III, ECP Fund IV and ECP Fund V.
As previously announced, Closing is expected to occur during the first quarter of 2024.
Capitalised terms not otherwise defined in this announcement have the meaning given to them in the circular published on 2 October 2023.
ENQUIRIES:
Bridgepoint
| Analysts and investors Adam Key [email protected] +44 7833 748010 |
Media Christian Jones / James Murray [email protected] [email protected] +44 20 7034 3500 |
FGS Global (Public Relations Adviser to Bridgepoint)
Charles O'Brien / +44 20 7251 3801 / +44 7825 043 656
Anjali Unnikrishnan / +44 20 7251 3801 / +44 7826 534 233
Legal Entity Identifier (LEI): 213800KFNMVI8PDZX472
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
ACQNKKBQPBDDBKB